1 / 66

Liver function Organ = metabolism Gland = secretions

Metabolic regulation. Carbohydrate metabolism Lipid metabolism Amino acid metabolism De-toxification and excretion Bilirubin metabolism Storage - vitamins [A, D, B 12 ], Cu, Fe. Haemotological regulation. Phagocytosis and antigen presentation Plasma protein synthesis

Download Presentation

Liver function Organ = metabolism Gland = secretions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Metabolic regulation Carbohydrate metabolism Lipid metabolism Amino acid metabolism De-toxification and excretion Bilirubin metabolism Storage - vitamins [A, D, B12], Cu, Fe Haemotological regulation Phagocytosis and antigen presentation Plasma protein synthesis Removal of circulating hormones Removal of antibodies Removal /storage of toxins Liver functionOrgan = metabolismGland = secretions Bile production

  2. Carbohydrate metabolism Glycogenesis Glycogenolysis Gluconeogenesis IMPAIRMENT Hypoglycaemia Glucose Intolerance http://static.howstuffworks.com/gif/diabetes-glucose-regulation.gif

  3. Lipid Metabolism • Lipoprotein synthesis • Oxidation of fats • Synthesis of cholesterol, phospholipids • Catabolism of steroids IMPAIRMENT Altered lipid profiles 2O Hyperaldosteronism →↑BP ↓K ↑pH 2O Hypercorticolism = Cushing’s disease Gonadal dysfunction → ∆ oestrogen:testestorone http://www.medscape.com/pi/editorial/clinupdates/2001/608/art-cu02.fig04.gif

  4. Amino acid metabolism • Deamination and transamination of amino acids • Removal of ammonia • Synthesis of amino acids Hepatic encephalopathy Hypoproteinaemia IMPAIRMENT Source: seqcore.brcf.med.umich.edu/ mcb500/aametov.gif

  5. Synthesis of hormones and plasma proteins……. • Insulin-like growth factor (IGF-1) → stimulated by pituitary growth hormone • Thrombopoietin → platelet production • Angiotensinogen (α-2-globulin) → hydrolysed by renin to angiotensin [renin-angiotensin-aldosterone system (RAAS)] • Heparin • Albumin • Extrinsic pathway clotting factors →I (fibrinogen), II (Prothrombin), IV, V, VI, and VII Clotting disorders, ↓ osmotic pressure IMPAIRMENT http://www.biosbcc.net/doohan/sample/images/blood%2520cells/clottingcascade

  6. Bile production …. Water Bile Acids e.g. taurocholic and glycocholic acid Electrolytes Cholesterol Phospholipids Bilirubin IMPAIRMENT • Malabsorption of fats and fat soluble vitamins • Jaundice http://sbsweb.bangor.ac.uk/images/bsx1016/sm_liver_position

  7. Detoxification – refer to Biochemistry and PK done in years 2/3. Phase I = modify Phase II = conjugate Reduced drug metabolism, reduced protein binding of drugs IMPAIRMENT http://www.aspartame-detox.info/images/brain-01.jpg

  8. Filtration – Reticuloendothelial system Blood filtration, phagocytosis of bacteria and other particulate matter IMPAIRMENT Source :www.bu.edu/histology/ i/15204loa.jpg Exposure to bacteria and other particles

  9. Symptoms of liver disease • Most symptoms non specific - anorexia, malaise, fatigue, fever • ↓ general health • cirrhotic habitus = wasted extremities plus protuberant abdomen with ascites • Generalised pruritus (itchiness) – due to retention of bile salts • Xanthelasma (fat build up under skin surface), xanthomas • Pale stools – lack of bile • Which of these is most specific? akimichi.homeunix.netXanthoma disappearance Document272 x 324 pixels - 55k - gif

  10. Disorders of coagulation/circulation • ↑ bleeding and bruising • ↑ prothrombin time (PT) → extrinsic clotting pathway (Prothrombin ratio (PR) and international normalized ratio (INR) are derived measures of PT). • Thrombocytopaenia (↓platelets) • Dysfibrinogenaemia (altered fibrinogen function) • Portal hypertension → endothelial stretching and shear stress → ↑ NO → systemic vasodilation = hyperdynamic circulation • Hepatopulmonary syndrome = pulmonary vasodilation → ↑blood flow (ventilation-perfusion mismatch) → arterial desaturation • Cyanosis and clubbing → enlargement of distal fingers and toes. Due to vasodilation? http://www.nlm.nih.gov/medlineplus/ency/images/ency/fullsize/18127.jpg

  11. Liver disease? http://upload.wikimedia.org/wikipedia/en/thumb/e/e0/Gollum.PNG/220px-Gollum.PNG

  12. Other changes • ↑ parotid salivary gland → fatty infiltation • Gynecomastia (mammary gland development in males), testicular atrophy, impotence • Amenorrhoea (absence of menstrual period) • Erythema (redness of skin) – build up of unmetabolised wastes in body http://www.sciencephoto.com/images/download_lo_res.html?id=771500153

  13. Jaundice • Icterus (icteric) • Accumulation of bilirubin = hyperbilirubinaemia • Skin, conjuctiva, mucous membranes • Dark urine from renal excretion of bilirubin http://www.modulomedico.com/fotos/imgJaundiceBig.jpg

  14. Serum chemistry/diagnostic testing • Breakdown product of haemoglobin • Globin = protein • Heme = iron containing → biliverdin (green bruising) → bilirubin → yellow (bruising/bile) • Bilirubin → conjugated with glucuronides in liver • Excreted in bile • Can be measured in the unconjugated (indirect) or conjugated (direct) form • Relatively insensitive indicator of liver disease Bilirubin Source:web.indstate.edu/thcme/ mwking/hemedegradation.jpg

  15. From Swaminathan – Handbook of Clinical Biochemistry 2004 From Beckett - Lecture Notes : Clinical Biochemistry 7th ed 2005

  16. Aminotransferases (ALT and AST) • Transaminase enzymes (aminotransferases) → reversible • transfer of an amino group between two a-keto acids. • Alanine aminotransferase = liver cytosol (ALT) • Aspartate aminotransferase = liver and other tissues (AST) • Reasonably sensitive indicators of liver disease, ALT >> AST Source: http://www.np.edu.sg/~dept-bio/biochemistry/aab/topics/asptrans.gif

  17. Alterations in ALT and AST Mild elevations(<100U/L) • Fatty liver/non-alcoholic steatohepatitis (fatty degeneration) • Chronic viral hepatitis Moderate elevations(100-300 U/L) • Acute or chronic hepatitis • Alcoholic hepatitis • Mild/moderate inflammation High elevated(>300 U/L) • Acute viral hepatitis • Hepatic necrosis → drugs or toxins • Ischemic hepatitis /circulatory shock. VALUES CAN BE 500-1500 U/L • Values >3000 U/L- toxic necrosis, or severe hypoxia AST/ALT ratio • Significant overlap between different conditions BUT • > 2 suggestive alcoholic liver disease (if ALT < 500 U/L) • < 1 viral hepatitis can ↑ratio as fibrosis and cirrhosis develop

  18. Alkaline phosphatases (ALP) • ALP = hydrolase →removes phosphate groups • Present in bile canaliculi, bone and placenta • ↑ sensitivity for hepatobiliary disease • ↓ specificity for hepatobiliary disease • Due to its numerous isoenzymes, its presence in non-hepatic tissues, and its sensitivity to drug induction

  19. Increases in liver ALP • Cholestasis, cholecystitis, cholangitis, cirrhosis, hepatitis, fatty liver, liver tumour, liver metastases, drug intoxication • Drugs e.g. verapamil, carbamazepine, phenytoin, erythromycin, allopurinol, ranitidine • ↑ → enhanced synthesis rather than hepatocytic leakage • ↓ ≠ clinically significant • If source ↑ ALP is not clear check other liver enzymes

  20. Gamma glutamyl transpeptidase (GGT) • GGT → hydrolysis of gamma-glutamyl peptide bonds • Biliary enzyme → obstruction of biliary tract + damage to biliary capillaries • Easily induced (alcohol, drugs) → disproportionately ↑ in alcoholic liver disease • Can be elevated in other diseases e.g. CHD, MI, COPD, pancreatitis, renal disease

  21. Patterns of enzyme alterations Ramachandran and Kakar J Clin Pathol 2009;62;481-492 Histological patterns in drug-induced liver disease

  22. ERCP = Endoscopic Retrograde Cholangiopancreatography From Beckett - Lecture Notes : Clinical Biochemistry 7th ed 2005

  23. From Beckett - Lecture Notes : Clinical Biochemistry 7th ed 2005

  24. Other tests • Haematology (anaemia, RBC parameters) • Clotting tests (PT) NOTE – these are vitamin K-dependent clotting factors • Lipid tests (total cholesterol, HDL, LDL, triglycerides) • Biochemistry (albumin, glucose) • Serology -Hepatitis virus -Antimitochondrial antibody (present in >90% of biliary cirrhosis cases) -Antinuclear factor- inflammatory marker -Antismooth muscle antibody-inflammatory marker -Alpha fetoprotein-hepatic carcinoma marker • Functional tests -Clearance tests (caffeine, bromosulphthalein), Elimination tests (galactose) • Imaging procedures -Abdominal radiographs -US, NMR, CT -Direct biliary visualisation → contrast studies • Liver Biopsy -Percutaneous -Surgical

  25. Drug Induced Liver Disease (DILD) • > 1000 drugs → DILD • ↑Hz drug withdrawal from the market R x Reference Hughes et al. Use of laboratory test data: a process guide and reference for health care professionals. 2nd Ed, PSA, 2009.

  26. Drug Induced Liver Disease (DILD) • Consider wherever altered liver function tests • However • Broad range of drugs • Wide variation in hepatic injury caused

  27. Drug Induced Liver Disease (DILD) • Types of hepatic injury • Hepatitis • Cholestasis • Mixed • Fibrosis • Granulomatous lesions • Neoplasms http://www.health-writings.com/img/mk/drug-induced-liver-disease/drugs_MIC062ML.jpg

  28. Drug induced hepatic failure http://www.path.cam.ac.uk/Normal/AR_Alimentary/LV_Liver/N_AR_LV_02.jpg http://mayoresearch.mayo.edu/mayo/research/nyberg_lab/images/histology.jpg

  29. Drug Induced Liver Disease (DILD) • Other changes (functional) • Enzyme induction and inhibition • Dietary /other deficiencies e.g. cysteine, Vit K • Steatosis = fatty change • Phospholipidosis

  30. Drug Induced Liver Disease (DILD) • Intrinsic • Dose related • Occurs within few days of use • Related to drug or toxic metabolite of drug • Known/reported/expected • Idiosyncratic • Unexpected • Variable latency • Not usually dose related

  31. Intrinsic - usually dose related:

  32. Idiosyncratic - usually hypersensitivity

  33. Factors affecting DILD • Age • Gender • Genetic factors • Nutritional status • Renal function • Dose and duration • Alcohol • Cigarette smoking • Other conditions- Hep C, HIV, RA

  34. Paracetamol toxicity • Paracetamol = #1 drug → calls to poisons information centres in Australia and NZ. 1 • Paracetamol = #1 drug overdose → hospital presentation and admission. 2,3 • Hepatic failure and death → uncommon outcomes • #1 cause of acute fulminant hepatic failure in Western countries.4 Buckley N, Eddleston M. Paracetamol (acetaminophen) poisoning. Clin Evid 2005; (14): 1738-1744. Dart RC, Erdman AR, Olson KR, et al. Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila) 2006; 44: 1-18. Linden CH, Rumack BH. Acetaminophen overdose. Emerg Med Clin North Am 1984; 2: 103-119. Ostapowicz G, Fontana RJ, Schiødt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947-954.

  35. Phases of paracetamol hepatotoxicity • PHASE 3 (72-96 H) • Centrilobular hepatic necrosis with continued abdominal pain • Jaundice • Coagulopathy • Hepatic encephalopathy • Nausea and vomiting • Renal failure • Fatality • PHASE 4 (4 D TO 3 WK) • Complete resolution of symptoms • Complete resolution of organ failure • PHASE 1 (0-24 H) • Asymptomatic • Anorexia • Nausea or vomiting • Malaise • Subclinical rise in serum transaminases levels begins at about 12 hours postingestion • PHASE 2 (18-72 H) • Right upper quadrant abdominal pain, anorexia, nausea, vomiting • Continued rise in serum transaminases levels • Admitted to hospital

  36. Paracetamol toxicity • Toxicity when GSH reserves overwhelmed by N-acetyl-p-benzoquinone imine (NAPQi) • ± gastric lavage and activated charcoal • Treatment → IV N-acetylcysteine http://drugdiscoveryopinion.com/images/paracetamol_metabolism.jpg

  37. Management plan- dose thresholds for NAC treatment ≠ serum readings <4 hours of poisoning Frank F S Daly, John S Fountain, Lindsay Murray, Andis Graudins and Nicholas ABuckley(2008).Guidelines for the management of paracetamol poisoning in Australia and New Zealand — explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. MJA 2008; 188 (5): 296-302.

  38. Management Plan Source- Frank F S Daly, John S Fountain, Lindsay Murray, Andis Graudins and Nicholas ABuckley(2008).Guidelines for the management of paracetamol poisoning in Australia and New Zealand — explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. MJA 2008; 188 (5): 296-302. Source: Frank F S Daly, John S Fountain, Lindsay Murray, Andis Graudins and Nicholas A Buckley(2008).Guidelines for the management of paracetamol poisoning in Australia and New Zealand — explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. MJA 2008; 188 (5): 296-302.

  39. Management Plan cont… Source- Frank F S Daly, John S Fountain, Lindsay Murray, Andis Graudins and Nicholas ABuckley(2008).Guidelines for the management of paracetamol poisoning in Australia and New Zealand — explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. MJA 2008; 188 (5): 296-302. Source: Frank F S Daly, John S Fountain, Lindsay Murray, Andis Graudins and Nicholas A Buckley(2008).Guidelines for the management of paracetamol poisoning in Australia and New Zealand — explanation and elaboration. A consensus statement from clinical toxicologists consulting to the Australasian poisons information centres. MJA 2008; 188 (5): 296-302.

  40. Management Plan cont… • Monitoring of liver function • Post –discharge patient education • Referral to Psychologist if needed

  41. Kava (Piper methysticum) • Kava = plant native to South Pacific Islands • Western society → herbal remedy anxiety • Kavalactones = active components -6 KL ~ 95% of the activity • Anxiolytic effect ~ benzodiazepines -few side effects -limited cognitive and motor impairment • Kava → hepatotoxicity e.g. hepatitis, cirrhosis, fulminant liver failure, death • Banned in many countries • Australia → voluntary recall 2002

  42. Isolated Perfused Rat Liver (IPRL) PUMP • Perfusate • Kavalactone • 95% O2/5% CO2 • Taurocholic acid • Krebs-Henseleit (KH) buffer Inferior Vena Cava Hepatic Portal Vein 37°C

  43. 10 µg/mL Kavain for 2 hours is hepatotoxic in IPRL studies Light Microscopy Scanning Electron Microscopy Control Liver Following Kavain Treatment Fu (2008) World J Gastroenterology 14: 541-546

  44. Membranes and electron dense structures Distorted cell nuclei Autophagosome Whirled ER surrounding mitochondrion

  45. Advice for case studies • Common things occur commonly. • Uncommon things don’t. • When you have eliminated the impossible, whatever remains, however improbable, must be the truth. Sherlock Holmes - The Sign of the Four (1890)

  46. Case Study #1 – history and signalment • 68 YO male retired labourer • Lethargy but no pain • BW ↓19kg in the last 3 months • Eating normally up to last 3 weeks • Dark urine and pale stools • ‘Moderate’ drinker throughout lifetime

  47. Clinical findings • Jaundice • Weakness • Palpable, non-tender mass in upper RHS abdominal quadrant

  48. Serum chemistry • Bilirubin predominantly conjugated • ↑↑ ALP and GGT • Predominantly cholestasis • Pancreatic tumour obstructing common bile duct

  49. Case Study #2 – history and signalment • 21 YO female student • Flu-like symptoms for 2 days • Condition deteriorating – dark urine, vomiting • Recently returned from long holiday in Asia

More Related